Bile duct cancer, Biliary tree cancers, Breast cancer, Ovarian cancer, Secondary cancers, Womb (uterine or endometrial) cancer
Open
Phase 1/2
This study is looking at a drug called AZD8205. It is for solid cancers that have spread to another part of the body or have come back after treatment. A solid cancer is any cancer apart from a blood cancer such as leukaemia.
It is open to people with:
Recruitment start: 31 October 2023
Recruitment end: 29 October 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
AstraZeneca
Last reviewed: 28 January 2024
CRUK internal database number: 19421